PortfoliosLab logoPortfoliosLab logo
XBI vs. FBT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XBI vs. FBT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Biotech ETF (XBI) and First Trust Amex Biotechnology Index (FBT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XBI achieves a 6.48% return, which is significantly lower than FBT's 7.08% return. Both investments have delivered pretty close results over the past 10 years, with XBI having a 8.53% annualized return and FBT not far ahead at 8.86%.


XBI

1D
1.62%
1M
-2.75%
YTD
6.48%
6M
6.92%
1Y
58.25%
3Y*
14.73%
5Y*
0.59%
10Y*
8.53%

FBT

1D
2.92%
1M
6.19%
YTD
7.08%
6M
3.95%
1Y
35.94%
3Y*
12.40%
5Y*
6.79%
10Y*
8.86%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XBI vs. FBT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XBI
SPDR S&P Biotech ETF
6.48%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-15.28%43.77%
FBT
First Trust Amex Biotechnology Index
7.08%24.25%5.88%2.55%-4.83%-2.26%12.96%19.74%-0.30%37.07%

Correlation

The correlation between XBI and FBT is 0.79, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.79

Correlation (3Y)
Calculated over the trailing 3-year period

0.82

Correlation (5Y)
Calculated over the trailing 5-year period

0.85

Correlation (10Y)
Calculated over the trailing 10-year period

0.88

Correlation (All Time)
Calculated using the full available price history since Jun 26, 2006

0.88

The correlation between XBI and FBT has been stable across timeframes, ranging from 0.79 to 0.88 - a consistent structural relationship.

XBI vs. FBT - Sectors Allocation Comparison


Sectors
XBI
FBT

Healthcare

99.8%
100.0%

Financial Services

0.2%

-

Basic Materials

0.2%

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XBI
99.8%
FBT
100.0%

Financial Services

XBI
0.2%
FBT

-

Basic Materials

XBI
0.2%
FBT

-

Communication Services

XBI

-

FBT

-

Consumer Cyclical

XBI

-

FBT

-

Consumer Defensive

XBI

-

FBT

-

Energy

XBI

-

FBT

-

Industrials

XBI

-

FBT

-

Real Estate

XBI

-

FBT

-

Technology

XBI

-

FBT

-

Utilities

XBI

-

FBT

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XBI vs. FBT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBI
XBI Risk / Return Rank: 7474
Overall Rank
XBI Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 6767
Sortino Ratio Rank
XBI Omega Ratio Rank: 6060
Omega Ratio Rank
XBI Calmar Ratio Rank: 9191
Calmar Ratio Rank
XBI Martin Ratio Rank: 8585
Martin Ratio Rank

FBT
FBT Risk / Return Rank: 4949
Overall Rank
FBT Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
FBT Sortino Ratio Rank: 5252
Sortino Ratio Rank
FBT Omega Ratio Rank: 4848
Omega Ratio Rank
FBT Calmar Ratio Rank: 5252
Calmar Ratio Rank
FBT Martin Ratio Rank: 4545
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBI vs. FBT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and First Trust Amex Biotechnology Index (FBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XBIFBTDifference
Sharpe ratioReturn per unit of total volatility

+0.56

Sortino ratioReturn per unit of downside risk

+0.60

Omega ratioGain probability vs. loss probability

1.38

1.31

+0.07

Calmar ratioReturn relative to maximum drawdown

6.02

2.53

+3.49

Martin ratioReturn relative to average drawdown

18.30

7.43

+10.87

XBI vs. FBT - Sharpe Ratio Comparison

The current XBI Sharpe Ratio is 2.30, which is higher than the FBT Sharpe Ratio of 1.74. The chart below compares the historical Sharpe Ratios of XBI and FBT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


XBIFBTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.30

1.74

+0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.02

0.31

-0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.27

0.37

-0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

0.36

0.51

-0.15

Drawdowns

XBI vs. FBT - Drawdown Comparison

The maximum XBI drawdown since its inception was -63.89%, which is greater than FBT's maximum drawdown of -40.51%. Use the drawdown chart below to compare losses from any high point for XBI and FBT.


Loading charts...

Drawdown Indicators


XBIFBTDifference

Max Drawdown

Largest peak-to-trough decline

-63.89%

-40.51%

-23.38%

Max Drawdown (1Y)

Largest decline over 1 year

-9.72%

-14.26%

+4.54%

Max Drawdown (3Y)

Largest decline over 3 years

-32.99%

-20.05%

-12.94%

Max Drawdown (5Y)

Largest decline over 5 years

-54.71%

-29.05%

-25.66%

Max Drawdown (10Y)

Largest decline over 10 years

-63.89%

-32.37%

-31.52%

Current Drawdown

Current decline from peak

-24.96%

-0.72%

-24.24%

Average Drawdown

Average peak-to-trough decline

-20.93%

-11.17%

-9.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.19%

4.85%

-1.66%

Volatility

XBI vs. FBT - Volatility Comparison

SPDR S&P Biotech ETF (XBI) has a higher volatility of 9.26% compared to First Trust Amex Biotechnology Index (FBT) at 6.94%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than FBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XBIFBTDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.26%

6.94%

+2.32%

Volatility (6M)

Calculated over the trailing 6-month period

20.18%

15.87%

+4.31%

Volatility (1Y)

Calculated over the trailing 1-year period

25.50%

20.79%

+4.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.18%

21.89%

+10.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.00%

23.91%

+8.09%

XBI vs. FBT - Expense Ratio Comparison

XBI has a 0.35% expense ratio, which is lower than FBT's 0.57% expense ratio.


Dividends

XBI vs. FBT - Dividend Comparison

XBI's dividend yield for the trailing twelve months is around 0.34%, while FBT has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
FBT
First Trust Amex Biotechnology Index
0.00%0.00%0.71%0.00%0.00%1.37%0.00%0.00%0.00%0.00%0.00%0.12%
XBI
SPDR S&P Biotech ETF
0.34%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Frequently Asked Questions


XBI and FBT have a correlation of 0.79, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XBI has higher volatility (9.26%) compared to FBT (6.94%). In terms of maximum drawdown, XBI dropped -63.89% vs FBT's -40.51%.

On 10-year performance, FBT leads with 8.86% vs 8.53% for XBI. On fees, XBI is cheaper at 0.35% per year. On volatility, FBT has been the lower-risk option at 6.94%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, FBT has performed better with a 8.86% return vs 8.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XBI is cheaper with a 0.35% expense ratio, compared with 0.57% for FBT.

XBI has the higher dividend yield at 0.34%, compared with 0.00% for FBT.

XBI tracks S&P Biotechnology Select Industry Index, while FBT tracks NYSE Arca Biotechnology Index. They also come from different issuers: State Street and First Trust. Their fees differ too: 0.35% for XBI and 0.57% for FBT.

XBI currently has the higher Sharpe Ratio (2.30 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XBI and FBT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer